Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aclaris Therapts (NQ: ACRS ) 2.090 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aclaris Therapts < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Monday's Pre-Market Session October 28, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session October 25, 2024 Via Benzinga Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying July 23, 2024 Via Benzinga 3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices July 11, 2024 Beaten-down stocks offer value to investors, but not all are worth buying. This is a look at three biopharma at long-term lows with catalysts for higher prices. Via MarketBeat Aclaris Therapeutics: Q4 Earnings Insights February 27, 2024 Via Benzinga The Analyst Landscape: 4 Takes On Aclaris Therapeutics January 11, 2024 Via Benzinga Breaking Down Aclaris Therapeutics: 6 Analysts Share Their Views December 18, 2023 Via Benzinga Aclaris Therapeutics Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) December 18, 2023 Via Benzinga Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying July 08, 2024 Via Benzinga $1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying June 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 24, 2024 Via Benzinga ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 ACRS stock results show that Aclaris Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Biotech’s Role in Addressing the Pancreatic Cancer Emergency March 14, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END Via FinancialNewsMedia Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying March 06, 2024 The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades January 22, 2024 HC Wainwright downgrades Aclaris Therapeutics post Phase 2b results of ATI-1777 for atopic dermatitis. Analyzing efficacy, commercial prospects, and competitive landscape. Via Benzinga Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 22, 2024 Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the... Via Benzinga Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket January 22, 2024 Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 16, 2024 Via Benzinga Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today? January 16, 2024 Aclaris Therapeutics leadership changes and strategic review. Preliminary unaudited data as of Dec 31, 2023, reveals approximately $182M in cash, cash equivalents, and marketable securities. Aclaris... Via Benzinga Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations January 10, 2024 Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to Via Benzinga Crude Oil Falls 1%; Amarin Shares Spike Higher January 10, 2024 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 10, 2024 Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 10, 2024 Via Benzinga Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week January 10, 2024 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P... Via Benzinga Topics Stocks Exposures US Equities Aclaris Therapeutics Shares Fall On Mixed Results From Mid-Stage Eczema Trial January 10, 2024 Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to Via Benzinga Dow Surges 100 Points; PriceSmart Earnings Top Views January 10, 2024 U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.27% to 37,627.83 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 10, 2024 Via Benzinga Inflammatory Disease Focused Aclaris Therapeutics Reduces Staff After Failed Psoriatic Arthritis Study December 20, 2023 Aclaris Therapeutics Inc (NASDAQ: ACRS) announced the publication of the Phase 2a trial results of ATI-1777 in moderate to severe atopic dermatitis (AD) in the peer-reviewed Via Benzinga Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket December 06, 2023 Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session December 05, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
